Applied Evidence

The family physician’s role in long COVID management

Author:

Nicole L. Mayo, PhD, MS

Rachel L. Ellenbogen, MD

Michael D. Mendoza, MD, MPH, MS

Holly Ann Russell, MD, MS

A paucity of both data and therapeutics presents obstacles to care and makes your role in symptom management, psychological support, and referral—...

• Read More

Applied Evidence

A practical guide to hidradenitis suppurativa

Author:

Cristina Marti-Amarista, MD

Mayur Rali, MD

Early diagnosis and treatment of hidradenitis suppurativa is key to avoiding severe disease and minimizing its negative psychological impact.

• Read More

Case Reports

40-year-old woman • fever • rash • arthralgia • Dx?

Author:

Farah Leclercq, DO

Velyn Wu, MD, MACM, FAAFP, CAQSM

► Fever
► Rash
► Arthralgia

• Read More

Clinical Inquiries

How does gender-affirming hormone therapy affect QOL in transgender patients?

Author:

Sarah Wilhelm, MD

Gary Kelsberg, MD

Sarah Safranek, MLIS

EVIDENCE-BASED ANSWER: There are modest effects on depression but not anxiety. ­Gender-affirming hormone therapy (GAHT) is associated with modest...

• Read More

Dx Across the Skin Color Spectrum

Erythrasma

Author:

Mavra Masood, MD, PGY-1

Candrice R. Heath, MD

Richard P. Usatine, MD

Erythrasma is a skin condition caused by acute or chronic infection of the outermost layer of the epidermis (stratum corneum) with ...

• Read More

Article

A reason for hope in the face of long COVID

Author:

Henry C. Barry, MD, MS

What we know about long COVID appears to be following the early course of its parent illness.

• Read More

Photo Rounds

A worsening abdominal rash

Author:

Diane Fernandes, DO

Eddie Kwan, MD

Brittany Lenz, MD

The confluence of 2 treatments (one appropriate, one not) led to a challenge in diagnosing this worsening rash.

• Read More

Photo Rounds

Teen with hyperpigmented skin lesions

• Read More

Photo Rounds

Macules and abdominal pain

• Read More

Photo Rounds

Incidental skin finding

• Read More

Photo Rounds

Blue-black hyperpigmentation on the extremities

Author:

Nora S. Ali, MD

Mauricio F. Jin, BS

David A. Wetter, MD

In some cases, diagnosis entails less “what is it?” and more “what caused it?”

• Read More

Practice Alert

Why you (still) shouldn’t prescribe hormone therapy for disease prevention

Author:

Doug Campos-Outcalt, MD, MPA

The USPSTF has reaffirmed its recommendation against using hormone therapy for chronic disease prevention in postmenopausal women. Here’s a look...

• Read More

Practice Alert

Whom to screen for anxiety and depression: Updated USPSTF recommendations

Author:

Doug Campos-Outcalt, MD, MPA

New guidance is offered concerning anxiety in children, adolescents, and adults. Advantages of particular screening tests are reviewed.

• Read More

PURLs

Consider this SGLT2 inhibitor for patients with HF with preserved ejection fraction

Author:

Sanketh Produttur, MD

Gregory Castelli, PharmD, BCPS, BC-ADM, CDCES

The addition of empagliflozin to usual therapy reduced hospitalization risk, regardless of patients’ diabetes status.

• Read More